Related Experiment Video
Updated: Sep 1, 2025

06:48
Author Spotlight: Evaluation of Protein-Condensate Dynamics in Live Human Cells
Published on: January 5, 2024
4.0K
Modulating biomolecular condensates: a novel approach to drug discovery
Diana M Mitrea1, Matthäus Mittasch2, Beatriz Ferreira Gomes2
1Dewpoint Therapeutics, Boston, MA, USA.
Nature Reviews. Drug Discovery
|August 16, 2022
Summary
Biomolecular condensates are essential for cellular functions and disease. This perspective explores a new drug discovery approach targeting these cellular structures, known as condensate-modifying therapeutics.
Area of Science:
- Cell Biology
- Biochemistry
- Molecular Medicine
Background:
- Membraneless assemblies called biomolecular condensates are crucial for cellular functions, compartmentalizing proteins and nucleic acids.
- These condensates often form via phase separation, creating distinct cellular microenvironments.
- Understanding condensate roles in health and disease is rapidly advancing.
Purpose of the Study:
- To propose a novel drug discovery strategy focused on biomolecular condensates.
- To explore the potential of condensate-modifying therapeutics (c-mods).
- To discuss the strategies, techniques, and challenges associated with this new therapeutic approach.
Main Methods:
- Literature review and synthesis of current research on biomolecular condensates.
- Conceptual framework development for condensate-modifying therapeutics.
- Analysis of existing and potential therapeutic strategies targeting phase separation.
Main Results:
- Biomolecular condensates play significant roles in both normal cellular states and various human diseases.
- Phase separation is a key mechanism underlying condensate formation and function.
- Targeting biomolecular condensates offers novel therapeutic opportunities.
Conclusions:
- The study highlights the potential of a new drug discovery paradigm centered on modulating biomolecular condensates.
- Condensate-modifying therapeutics (c-mods) represent a promising avenue for treating diseases associated with condensate dysfunction.
- Further research into condensate biology and therapeutic targeting is warranted.
More Related Videos
Related Concept Videos
Drug Discovery: Overview
8.6K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
8.6K
Cooperative Allosteric Transitions
8.0K
Cooperative allosteric transitions can occur in multimeric proteins, where each subunit of the protein has its own ligand-binding site. When a ligand binds to any of these subunits, it triggers a conformational change that affects the binding sites in the other subunits; this can change the affinity of the other sites for their respective ligands. The ability of the protein to change the shape of its binding site is attributed to the presence of a mix of flexible and stable segments in the...
8.0K
Targets for Drug Action: Overview
7.3K
Drugs target macromolecules to modify ongoing cellular processes. Primary drug targets include receptors, ion channels, transporters, and enzymes.
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
7.3K

